These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12532679)

  • 21. No evidence of a mild form of inhalational Bacillus anthracis infection during a bioterrorism-related inhalational anthrax outbreak in Washington, D.C., in 2001.
    Baggett HC; Rhodes JC; Fridkin SK; Quinn CP; Hageman JC; Friedman CR; Dykewicz CA; Semenova VA; Romero-Steiner S; Elie CM; Jernigan JA
    Clin Infect Dis; 2005 Oct; 41(7):991-7. PubMed ID: 16142664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pakistan's experience of a bioterrorism-related anthrax scare.
    Ahmad K; Dil AS; Kazi BM; Us-Saba N; Ansari J; Nomani K
    East Mediterr Health J; 2004; 10(1-2):19-26. PubMed ID: 16201705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medical management of biological warfare and bioterrorism: place of the immunoprevention and the immunotherapy.
    Binder P; Attre O; Boutin JP; Cavallo JD; Debord T; Jouan A; Vidal D
    Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):401-21. PubMed ID: 12818625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histopathology and immunohistochemistry in the diagnosis of bioterrorism agents.
    Guarner J; Zaki SR
    J Histochem Cytochem; 2006 Jan; 54(1):3-11. PubMed ID: 16148309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioterrorism: what level is the threat and are vaccines the answer?
    Smith LA
    Expert Rev Vaccines; 2004 Oct; 3(5):493-5. PubMed ID: 15485326
    [No Abstract]   [Full Text] [Related]  

  • 26. [Bioterrorism].
    Sata T
    Nihon Hoigaku Zasshi; 2005 Oct; 59(2):119-25. PubMed ID: 16296383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased detection of rickettsialpox in a New York City hospital following the anthrax outbreak of 2001: use of immunohistochemistry for the rapid confirmation of cases in an era of bioterrorism.
    Koss T; Carter EL; Grossman ME; Silvers DN; Rabinowitz AD; Singleton J; Zaki SR; Paddock CD
    Arch Dermatol; 2003 Dec; 139(12):1545-52. PubMed ID: 14676069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anthrax 2001--lessons learned by public health laboratories.
    Heatherley SS
    Clin Lab Sci; 2002; 15(3):183-6. PubMed ID: 12778966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microbial forensics aims to link pathogen, crime, and perpetrator.
    Larkin M
    Lancet Infect Dis; 2003 Apr; 3(4):180. PubMed ID: 12679247
    [No Abstract]   [Full Text] [Related]  

  • 30. Biosecurity. Paul Keim on his life with the FBI during the anthrax investigation. Interview by Yudhijit Bhattacharjee.
    Keim P
    Science; 2009 Mar; 323(5920):1416. PubMed ID: 19286527
    [No Abstract]   [Full Text] [Related]  

  • 31. Heading-off anthrax at Hamilton, New Jersey: events of October 2001.
    Godyn JJ
    N J Med; 2005; 102(1-2):51-4. PubMed ID: 15790066
    [No Abstract]   [Full Text] [Related]  

  • 32. An epidemiologist's view of bioterrorism. Eddy A. Bresnitz, MD, MS, discusses state initiatives and preparedness. Interview by Leah Z. Ziskin.
    Bresnitz EA
    N J Med; 2003 Apr; 100(4):12-9; quiz 19-22. PubMed ID: 12703333
    [No Abstract]   [Full Text] [Related]  

  • 33. A silent bomb: the risk of anthrax as a weapon of mass destruction.
    Webb GF
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4355-6. PubMed ID: 12682291
    [No Abstract]   [Full Text] [Related]  

  • 34. Bioterrorism for the respiratory physician.
    Waterer GW; Robertson H
    Respirology; 2009 Jan; 14(1):5-11. PubMed ID: 19144044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anthrax investigation. Six anthrax science questions the FBI has yet to answer.
    Bhattacharjee Y; Enserink M
    Science; 2008 Aug; 321(5892):1027. PubMed ID: 18719255
    [No Abstract]   [Full Text] [Related]  

  • 36. Anthrax in New Jersey: a health education experience in bioterrorism response and preparedness.
    Miro S; Kaufman SG
    Health Promot Pract; 2005 Oct; 6(4):430-6. PubMed ID: 16210685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Threat or creation of panic? Disease agents as terror weapons].
    Holzgreve H
    MMW Fortschr Med; 2004 Sep; 146(35-36):4-6. PubMed ID: 15540528
    [No Abstract]   [Full Text] [Related]  

  • 38. Biodefence on the research agenda.
    Fauci AS
    Nature; 2003 Feb; 421(6925):787. PubMed ID: 12594484
    [No Abstract]   [Full Text] [Related]  

  • 39. Ethics and bioterrorism research.
    Bull Med Ethics; 2004 May; (198):13-20. PubMed ID: 15832477
    [No Abstract]   [Full Text] [Related]  

  • 40. US restrictions limit anthrax networking.
    Ozin A; Bade K; Kaufmann SH
    Nature; 2004 Oct; 431(7011):897. PubMed ID: 15496891
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.